Annual Accounts Receivable
$0.00
-$94.00 K-100.00%
31 December 2023
Summary:
VBI Vaccines annual accounts receivable is currently $0.00, with the most recent change of -$94.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$77.00 thousand (-100.00%).VBIV Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$227.00 K
+$227.00 K+100.00%
31 March 2024
Summary:
VBI Vaccines quarterly accounts receivable is currently $227.00 thousand, with the most recent change of +$227.00 thousand (+100.00%) on 31 March 2024. Over the past year, it has dropped by -$126.00 thousand (-35.69%).VBIV Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | -35.7% |
| 3 y3 years | -100.0% | +530.6% |
| 5 y5 years | -100.0% | +17.0% |
VBIV Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -100.0% | -85.6% |
VBI Vaccines Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $227.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $353.00 K(+346.8%) |
| June 2023 | - | $79.00 K(-71.9%) |
| Mar 2023 | - | $281.00 K(+198.9%) |
| Dec 2022 | $94.00 K(+1075.0%) | $94.00 K(-28.8%) |
| Sept 2022 | - | $132.00 K(-2.2%) |
| June 2022 | - | $135.00 K(+32.4%) |
| Mar 2022 | - | $102.00 K(+1175.0%) |
| Dec 2021 | $8000.00(-89.6%) | $8000.00(-77.8%) |
| Sept 2021 | - | $36.00 K(-60.0%) |
| June 2021 | - | $90.00 K(-47.7%) |
| Mar 2021 | - | $172.00 K(+123.4%) |
| Dec 2020 | $77.00 K(-61.7%) | $77.00 K(+185.2%) |
| Sept 2020 | - | $27.00 K(+22.7%) |
| June 2020 | - | $22.00 K(-83.6%) |
| Mar 2020 | - | $134.00 K(-33.3%) |
| Dec 2019 | $201.00 K(+258.9%) | $201.00 K(+3.6%) |
| Sept 2019 | - | $194.00 K(+246.4%) |
| June 2019 | - | $56.00 K(-52.1%) |
| Mar 2019 | - | $117.00 K(+108.9%) |
| Dec 2018 | $56.00 K(-60.8%) | $56.00 K(-54.8%) |
| Sept 2018 | - | $124.00 K(-27.9%) |
| June 2018 | - | $172.00 K(+3.0%) |
| Mar 2018 | - | $167.00 K(+16.8%) |
| Dec 2017 | $143.00 K(+1330.0%) | $143.00 K(-29.6%) |
| Sept 2017 | - | $203.00 K(-10.2%) |
| June 2017 | - | $226.00 K(+425.6%) |
| Mar 2017 | - | $43.00 K(+330.0%) |
| Dec 2016 | $10.00 K(-89.2%) | $10.00 K(-93.9%) |
| Sept 2016 | - | $163.00 K(+279.1%) |
| June 2016 | - | $43.00 K(-6.5%) |
| Mar 2016 | - | $46.00 K(-50.5%) |
| Dec 2015 | $93.00 K(+120.4%) | $93.00 K(-37.2%) |
| Sept 2015 | - | $148.00 K(+90.7%) |
| June 2015 | - | $77.60 K(+83.9%) |
| Mar 2015 | - | $42.20 K(+139.8%) |
| Mar 2015 | $42.20 K(+7.1%) | - |
| Dec 2014 | - | $17.60 K(+20.5%) |
| Sept 2014 | - | $14.60 K(-3.9%) |
| June 2014 | - | $15.20 K(-61.4%) |
| Mar 2014 | $39.40 K(-14.2%) | $39.40 K(+47.6%) |
| Dec 2013 | - | $26.70 K(-4.6%) |
| Sept 2013 | - | $28.00 K(-8.2%) |
| June 2013 | - | $30.50 K(-33.6%) |
| Mar 2013 | $45.90 K | $45.90 K(-32.2%) |
| Dec 2012 | - | $67.70 K(-38.3%) |
| Sept 2012 | - | $109.70 K(-51.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $227.30 K(-64.9%) |
| Mar 2012 | $648.40 K(+14.6%) | $648.40 K(-59.0%) |
| Dec 2011 | - | $1.58 M(+19.7%) |
| Sept 2011 | - | $1.32 M(+18.1%) |
| June 2011 | - | $1.12 M(+97.7%) |
| Mar 2011 | $565.60 K(>+9900.0%) | $565.60 K(+617.8%) |
| Dec 2010 | - | $78.80 K(+50.1%) |
| Sept 2010 | - | $52.50 K(+48.3%) |
| June 2010 | - | $35.40 K(+580.8%) |
| Mar 2010 | $5200.00(-94.8%) | $5200.00(-79.6%) |
| Dec 2009 | - | $25.50 K(+23.8%) |
| Sept 2009 | - | $20.60 K(-0.5%) |
| June 2009 | - | $20.70 K(-79.2%) |
| Mar 2009 | $99.60 K(+137.7%) | $99.60 K(+896.0%) |
| Dec 2008 | - | $10.00 K(-31.0%) |
| Sept 2008 | - | $14.50 K(-44.9%) |
| June 2008 | - | $26.30 K(-37.2%) |
| Mar 2008 | $41.90 K(+82.2%) | $41.90 K(-53.1%) |
| Dec 2007 | - | $89.40 K(-21.6%) |
| Sept 2007 | - | $114.10 K(+155.3%) |
| June 2007 | - | $44.70 K(+94.3%) |
| Mar 2007 | $23.00 K(-55.3%) | $23.00 K(+7.5%) |
| Dec 2006 | - | $21.40 K(+201.4%) |
| Sept 2006 | - | $7100.00(-86.3%) |
| June 2006 | - | $52.00 K(+1.0%) |
| Mar 2006 | $51.50 K(+400.0%) | $51.50 K(+165.5%) |
| Dec 2005 | - | $19.40 K(-14.5%) |
| Sept 2005 | - | $22.70 K(+23.4%) |
| June 2005 | - | $18.40 K(+78.6%) |
| Mar 2005 | $10.30 K(+33.8%) | $10.30 K(-82.3%) |
| Dec 2004 | - | $58.30 K(+91.8%) |
| Sept 2004 | - | $30.40 K(+40.7%) |
| June 2004 | - | $21.60 K(+180.5%) |
| Mar 2004 | $7700.00(+413.3%) | $7700.00(+234.8%) |
| Dec 2003 | - | $2300.00(+64.3%) |
| Sept 2003 | - | $1400.00(-50.0%) |
| June 2003 | - | $2800.00(+86.7%) |
| Mar 2003 | $1500.00(-65.9%) | $1500.00(+275.0%) |
| Dec 2002 | - | $400.00(-81.8%) |
| Sept 2002 | - | $2200.00(-8.3%) |
| June 2002 | - | $2400.00(-45.5%) |
| Mar 2002 | $4400.00(-69.7%) | $4400.00(-15.4%) |
| Dec 2001 | - | $5200.00(-25.7%) |
| Sept 2001 | - | $7000.00(+4.5%) |
| June 2001 | - | $6700.00(-53.8%) |
| Mar 2001 | $14.50 K(-79.4%) | $14.50 K(-47.5%) |
| Dec 2000 | - | $27.60 K(-7.4%) |
| Sept 2000 | - | $29.80 K(-57.7%) |
| Mar 1998 | $70.40 K | $70.40 K |
FAQ
- What is VBI Vaccines annual accounts receivable?
- What is the all time high annual accounts receivable for VBI Vaccines?
- What is VBI Vaccines annual accounts receivable year-on-year change?
- What is VBI Vaccines quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for VBI Vaccines?
- What is VBI Vaccines quarterly accounts receivable year-on-year change?
What is VBI Vaccines annual accounts receivable?
The current annual accounts receivable of VBIV is $0.00
What is the all time high annual accounts receivable for VBI Vaccines?
VBI Vaccines all-time high annual accounts receivable is $648.40 K
What is VBI Vaccines annual accounts receivable year-on-year change?
Over the past year, VBIV annual accounts receivable has changed by -$94.00 K (-100.00%)
What is VBI Vaccines quarterly accounts receivable?
The current quarterly accounts receivable of VBIV is $227.00 K
What is the all time high quarterly accounts receivable for VBI Vaccines?
VBI Vaccines all-time high quarterly accounts receivable is $1.58 M
What is VBI Vaccines quarterly accounts receivable year-on-year change?
Over the past year, VBIV quarterly accounts receivable has changed by -$126.00 K (-35.69%)